HFSA Annual Scientific Meeting 2023

Where heart failure teams gather…

HFSA Annual Scientific Meeting : October 6 - 9, 2023
Huntington Convention Center of Cleveland
Cleveland, Ohio

The HFSA Annual Scientific Meeting has gained a reputation as an outstanding forum for presentation of the latest information available (clinical and basic research, treatment and care of patients) in the field of heart failure. It is the CAN’T-MISS meeting for all members of the heart failure care team, featuring a robust, team-based educational program taught by a multidisciplinary line-up of industry experts.

The meeting provides a national forum focused entirely on heart failure for industry leaders to share experiences and expertise through symposia, lectures, debates, poster presentations, and how-to workshops, while providing attendees enriching opportunities to network with colleagues. It is the place to be for cutting-edge research, the newest technologies, and proven best practices in heart failure care.

About the Heart Failure Society of America

The Heart Failure Society of America (HFSA) is a professional society devoted exclusively to improving and expanding heart failure care through collaboration, education, research, innovations, and advocacy.

HFSA is the only organization in America representing all members of the multidisciplinary heart failure team, including 2,000+ physicians, nurses, pharmacists, scientists, as well as 1,000+ patients. HFSA is driven by a vision to reduce the burden of heart failure on patients and families worldwide.

Meeting Location

The HFSA Annual Scientific Meeting 2023 will be held at the Huntington Convention Center of Cleveland of Cleveland.

300 Lakeside Avenue
Cleveland, Ohio, 44113

Phone: +1 216-928-1600
Website: Huntington Convention Center of Cleveland

Why You Should Exhibit

HFSA’s ASM is one of the only cardiology meetings focused exclusively on heart failure.
Interact with visionary and dedicated leaders in the heart failure field who are interested in keeping up with the latest treatments, technologies and products.

Access All Members of the Heart Failure Team:

Cardiologists, CV Surgeons, Internists and Primary Care
Physicians
Clinical Researchers
Cardiac Rehabilitation Professionals

Nurses, Nurse Practitioners
Epidemiologists
Health Care Administrators
Industry

Pharmacists, Pharmacologists
Physician Assistants
Research Scientists

The attendees are primarily professionals dedicated to research and clinical care of patients with heart failure. They are highly motivated and interested in keeping abreast of the latest developments and advances in the treatment and care of heart failure patients. HFSA does not collect NPI numbers of attendees.

Attendee Demographics

2022 Exhibitors

Abbott
ABIOMED
Alnylam Pharmaceuticals
American Association of Heart Failure Nurses
America College of Cardiology
American Heart Association
American Regent, Inc.
American Society of Echocardiography
AstraZeneca
AstraZeneca/Ionis Medical Affairs
Boehringer Ingelheim Pharmaceuticals, Inc.
BioVentrix, Inc
BodiGuide Inc.
Bodyport Inc
Boston Scientific
BMS Medical Affairs
Bristol Myers Squibb
CardioSignal Inc
Cardiovascular Clinical Sciences

CareDx, Inc.
CMP Pharma
CorInnova, Inc.
Cormeum
CVRx
Cytokinetics
Daiichi Sankyo, Inc.
Daxor Corporation
Endotronix
General Prognostics (GPx)
GETINGE
Houston Shock Symposium
Impulse Dynamics
Innovaccer Inc.
Inova Heart and Vascular Institute
Invitae
Jant Pharmacal Corporation
Lantheus
Lexicon Pharmaceuticals, Inc.
Medtronic
Merck & Co., Inc.
Natera

Novartis Pharmaceuticals Corporation
Nuwellis, Inc.
OM1
One Lambda, Inc., A Thermo Fisher Scientific Brand
Paragonix
Pfizer
PhysioFlow/Manatec Biomedical
physIQ
Renovacor Inc.
Rhythm Science Inc
Sarfez Pharmaceuticals, Inc.
scPharmaceuticals
Sensible Medical
v-Wave Inc
VisCardia Inc.
Vyaire Medical
Ultromics
University of Maryland School of Pharmacy
ZOLL

Content last updated on April 7th, 2023 at 05:29 pm